Inventor · disambiguated record
Steven A. Rich
Also filed as: RICH STEVEN · RICH STEVEN A
17 granted patents·2 pending applications·47 citations·filing 1996–2024
91Inventor score
Files withRICH STEVEN6QAAM PHARMACEUTICALS LLC5RICH STEVEN A5HEALTH RESEARCH INC2STAT HEALTH INFORMATICS INC1
Top patents by PatentIndex Score
19 records- 0186US8969402B2Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseasesRICH STEVEN A·Filed 2013·Granted Mar 3, 2015·3 cites·9 claims
- 0278US8097633B2Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute deliriumRICH STEVEN A·Filed 2007·Granted Jan 17, 2012·3 cites·16 claims
- 0376US10487464B2Traffic coneRICH STEVEN·Filed 2017·Granted Nov 26, 2019·3 cites·11 claims
- 0474US2024423965A1Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disordersQAAM PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0573US11419850B2Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseasesQAAM PHARMACEUTICALS LLC·Filed 2019·Granted Aug 23, 2022·0 cites·39 claims
- 0673US9084753B2Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute deliriumRICH STEVEN A·Filed 2011·Granted Jul 21, 2015·2 cites·20 claims
- 0768US5834235AInferferon-α-induced proteinHEALTH RESEARCH INC·Filed 1996·Granted Nov 10, 1998·18 cites·7 claims
- 0867US9980941B2Quaternary ammonium anti-cholinergic muscarinic receptor antagonistsRICH STEVEN A·Filed 2014·Granted May 29, 2018·0 cites·3 claims
- 0967USD778194STraffic coneRICH STEVEN·Filed 2015·Granted Feb 7, 2017·9 cites·1 claims
- 1066US12109202B2Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disordersQAAM PHARMACEUTICALS LLC·Filed 2021·Granted Oct 8, 2024·0 cites·5 claims
- 1164US10376493B2Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseasesQAAM PHARMACEUTICALS LLC·Filed 2016·Granted Aug 13, 2019·0 cites·10 claims
- 1258USD791001STraffic coneRICH STEVEN·Filed 2016·Granted Jul 4, 2017·6 cites·1 claims
- 1358US9034890B2Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseasesRICH STEVEN A·Filed 2013·Granted May 19, 2015·0 cites·10 claims
- 1454US2025380905A1Systems and Methods for Ear Interface Mechanisms to Retain Wearable in Cymba Concha and Ensure Biosensor ContactSTAT HEALTH INFORMATICS INC·Filed 2024·Application pending·0 cites
- 1545US10323370B2Traffic coneRICH STEVEN·Filed 2017·Granted Jun 18, 2019·0 cites·9 claims
- 1642US10519109B2Glycopyrronium fatty acid salts and methods of making sameQAAM PHARMACEUTICALS LLC·Filed 2016·Granted Dec 31, 2019·0 cites·20 claims
- 1742USD791002STraffic coneRICH STEVEN·Filed 2016·Granted Jul 4, 2017·2 cites·1 claims
- 1834USD854957STraffic coneRICH STEVEN·Filed 2017·Granted Jul 30, 2019·1 cites·1 claims
- 1927US6060279AInterferon-α-induced proteinHEALTH RESEARCH INC·Filed 1998·Granted May 9, 2000·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Steven A. Rich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →